14/11/2022
Possible solutions to improve the European regulatory procedures for clinical trials with Advanced Therapy Medicinal Products consisting of or containing Genetically Modified Organisms
30/04/2020
A recent interview with Prof. Jennifer Doudna, a co-discoverer of the CRISPR-Cas9 system for genome editing, highlights potential applications of the technology to COVID-19.
09/03/2020
To ensure the EU remains a leader in ATMP innovation, this paper outlines and elaborates EuropaBio’s position and policy recommendations to the European Commission across three key focus areas.
30/11/2019
EuropaBio and its members strongly believe that genome editing will enable the development of many solutions to the grand challenges facing both people and planet.
25/06/2019
EuropaBio, the voice of the biotech industry, has developed this paper to bring the latest views from the developers and users of genome editing tools and applications.
09/05/2019
Open Letter to Member States on the EU Court Ruling on Mutagenesis.
29/11/2018
As EU court ruling risks blocking innovation, the European biotech industry calls for science-based political decision making on genome edited products.
27/09/2017
Possible solutions to improve the European regulatory procedures for clinical trials with Advanced Therapy Medicinal Products consisting of or containing Genetically Modified Organisms